Papillomavirus Vaccines (HPV Vaccines)

Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.

Also Known As:

HPV Vaccines; Human Papilloma Virus Vaccines; Papillomavirus Vaccine, Human; Papillomavirus Vaccines, Human; Vaccine, HPV; Vaccine, Human Papillomavirus; Vaccine, Papillomavirus; Vaccines, Human Papillomavirus; Vaccines, Papillomavirus; HPV Vaccine; Human Papilloma Virus Vaccine; Human Papillomavirus Vaccine; Human Papillomavirus Vaccines; Papillomavirus Vaccine

Networked: 3138 relevant articles (320 outcomes, 459 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1947
- Biological Products
  - Vaccines: 128365
    - Viral Vaccines: 473
      - Papillomavirus Vaccines: 3138
        18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent: 161
        18 L1 type 16 human papillomavirus vaccine: 107
        Human Papillomavirus Recombinant Vaccine nonavalent: 17
        MEDI0457: 6
        VGX-3100: 5
        GX-188 vaccine
        human papillomavirus type 18 L1 VLP vaccine
        TA human papillomavirus vaccine
        tipapkinogen sovacivec vaccine

Experts

1.	Markowitz, Lauri E: 48 articles (12/2024 - 09/2006)
2.	Garland, Suzanne M: 37 articles (08/2023 - 01/2007)
3.	Giuliano, Anna R: 36 articles (11/2023 - 11/2007)
4.	Brewer, Noel T: 35 articles (12/2023 - 08/2007)
5.	Saraiya, Mona: 29 articles (01/2022 - 09/2006)
6.	Unger, Elizabeth R: 28 articles (12/2024 - 02/2007)
7.	Ueda, Yutaka: 27 articles (04/2024 - 06/2015)
8.	Zimet, Gregory D: 25 articles (01/2023 - 12/2005)
9.	Hung, Chien-Fu: 23 articles (09/2021 - 01/2007)
10.	Smith, Jennifer S: 23 articles (01/2021 - 02/2008)

Related Diseases

1.	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/01/2018 - "Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer." 02/23/2022 - "Although HPV immunization has shown to be extremely effective in preventing a high proportion of cervical precancerous lesions and cervical cancers, HPV vaccines do not protect against all oncogenic high-risk HPV genotypes. " 01/01/2022 - "Prophylactic HPV vaccines are highly efficacious in preventing cervical cancer in Asian females. " 01/01/2021 - "Given that human papillomavirus vaccines are highly effective in the primary prevention of cervical cancer, it is important to explore the barriers and facilitators to vaccination uptake in areas where the burden of disease remains high. " 05/01/2014 - "However, because most cervical cancers are caused by HPV-16/18, it is unlikely that the nonavalent would be used if its efficacy against these types is lower than current HPV vaccines. "
2.	Neoplasms (Cancer) 08/18/2017 - "Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials." 04/01/2024 - "HPV vaccines are highly effective in preventing HPV-associated cancers; however, HPV vaccination uptake is low among Chinese students studying at U.S. " 12/14/2023 - "HPV vaccines, preferably administered before the onset of sexual activity, have demonstrated remarkable efficacy in preventing HPV-related cancers. " 12/01/2021 - "HPV vaccines have shown promising results in preventing HPV-associated cancers; however, the vaccination rate in Chinese college students remains extremely low. " 10/01/2019 - "HPV vaccines licensed from 2006 onwards offer protection against most HPV-related cancers, especially when introduced into national immunization programs. "
3.	Papillomavirus Infections 11/01/2006 - "Large phase 2 and 3 clinical trials with a quadrivalent preventive HPV vaccine (HPV 6/11/16/18) and phase 2 trials with a bivalent preventive HPV vaccine (HPV 16/18) have demonstrated that both products are highly efficacious in preventing type-specific HPV infections and HPV-related disease and are well tolerated. " 06/01/2022 - "Over the 18 month time-frame we studied, single-dose bivalent and nonavalent HPV vaccines were each highly effective in preventing incident persistent oncogenic HPV infection, similar to multidose regimens." 01/01/2019 - "HPV vaccine has been shown to be highly effective in preventing HPV infection, and understanding the genotypes of HPV infection can guide the utilization of HPV vaccine. " 01/01/2016 - "Only 45% of the respondents have ever heard about HPV vaccine and 37.8% of them knew that HPV vaccine is very effective in preventing HPV infection and its related precancerous/cancerous diseases. " 01/01/2020 - "Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals already infected. "
4.	Infections 12/31/2023 - "An important part of prophylactic HPV vaccine development is durable protection against infection and disease. " 08/28/2023 - "Background: men who have sex with men (MSM) are a high-risk group for human papillomavirus (HPV) infection, and the HPV vaccine is effective in preventing it. " 01/01/2023 - "Vaccination is effective against infection with high-risk HPV strains, yet HPV vaccine coverage is lower in the US than the national target. " 01/01/2016 - "HPV vaccines based on L1 virus-like particles (VLPs) provided a high degree of protection against HPVs infection. " 11/01/2007 - "To ensure protection against persistent human papillomavirus (HPV) infection and the subsequent development of cervical lesions, an effective HPV vaccine must be able to induce strong humoral immune responses. "
5.	Condylomata Acuminata (Genital Wart) 04/01/2010 - "The quadrivalent HPV vaccine has been shown to be highly efficacious in the prevention of genital warts in women and precancerous lesions of the cervix, vulva, and vagina. " 01/01/2021 - "Vaccination against human papillomavirus (HPV) has proven to be effective against severe cervical lesions and genital warts, whereas no previous study has provided real-world data on the HPV vaccine effectiveness against high-grade vulvovaginal lesions. " 11/01/2014 - "Our results add to evidence from clinic-based studies showing a significant reduction in genital warts among HPV vaccine-eligible women in the general community and increases in the proportion of Australian women diagnosed with chlamydia." 03/01/2019 - "Our results suggested that HPV vaccines could be effective in management of genital warts." 01/01/2017 - "Three doses of the quadrivalent HPV vaccine were effective against genital warts in our population. "

Related Drugs and Biologics

1.	Vaccines
2.	Papillomavirus Vaccines (HPV Vaccines)
3.	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)
4.	18 L1 type 16 human papillomavirus vaccine (Cervarix)
5.	Combined Vaccines
6.	Antibodies
7.	Therapeutic Uses
8.	Neutralizing Antibodies
9.	Cancer Vaccines
10.	Antigens

Related Therapies and Procedures

1.	Therapeutics
2.	Immunotherapy
3.	Condoms (Condom)
4.	Injections
5.	Intramuscular Injections